BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 122059
Published online Dec 9, 2026. doi: 10.5409/wjcp.122059
Table 1 Summary of genes identified in Kawasaki disease through whole exome sequencing, whole genome sequencing, and targeted sequencing approaches
Ref.
Cohort size
Sequencing approach
Genetic variants identified
rs IDs (reference SNP IDs)
Observed associations
Kim et al[23]6 family members including 2 siblings affected with KD (n = 6)WGSRare: TLR6, MEF2A common: ARRDC4, SLK, TACSTD2rs5743809, rs35220466, rs12650224, rs6822503, rs12645200, rs5743826, rs6837101, rs373652230, rs1552673, rs10786779, rs6584583 and rs14008TLR6-NF-κB signalling pathway upregulation
Kanda et al[42]Refractory KD (n = 1)WGSORAI1, BLKrs3741596 and rs2254546Calcineurin/NFAT signalling pathway upregulation
Shrestha et al[34]KD (n = 472)WGSFANK1, MAP2K3, KCNJ12, FRG1DP, FRG1BP, DEFB115, CWH43, CCZ1B, MIR3683, FRG1JP, FLJ43315rs77740910, rs73368612, rs113336767, rs75317727, C20_29079715, C20_30491365, C4_49554582, C7_6981323, C9_63906587IVIG resistance
CA10rs74255119IVIG responsiveness
Shrestha et al[35]KD (n = 504)WGSKLRC2, ZMAT4, NDUFA5, MICU2, PTPRD, TCAF2, WHAMM, LOC100127, ACTR3BP2, MYBPC3, FRG1DPrs62154092, rs28730284, rs9643846, rs9643847, rs57504215, rs60545202, rs59556769, rs73677451, rs12676292, rs4332118, rs6988966, rs10276547, rs10280266, rs600075, rs5896385, rs1218424730, rs11259953, rs11259954, rs34163760, rs12585631, rs1052373, rs1424006606, rs1396081550, rs1258107032, rs1379390981, rs1424309393Disease susceptibility, severity, and CAAs involving immune dysregulation, mitochondrial dysfunction and vascular remodelling pathways
Kim et al[33]KD (n = 200)WESFCRLA, PTGER4, IL17F, CARD11, SIGLEC10rs2275603, rs755244149, rs117796773, rs41493047, and rs201376644Disease susceptibility
IL31RA, FGFR4, FNDC1, MMP8, FOXN1rs148721785, rs201812753, rs374967242, rs61754773, and rs188424977Development of CAAs
Zhang et al[22]KD (n = 93)WESRBP3 and MYH14RBP3: c.2650G>A, MYH14: c.566G>A, MYH14: c.1109C>T, MYH14: c.3917T>G, MYH14: c.4301G>A, MYH14: c.5026C>T, MYH14: c.5329 C>T, MYH14: c.5393 C>A, and MYH14: c.5476 C>TRare coding variants
Xu et al[40]KD (n = 1272)WESUSH2A, LMO7, CEMIP, EFCC1rs148135241, rs142687160, rs12441101, and rs142391828Sex-biased variants
Wang et al[44]KD (n = 110)WESHLA-DRB1, IL6ST, IL17RC, VEGFB, ITPKC, CASP3, ORAI1, MYH11, SMAD9rs17882084, rs781455079, rs143781415, rs776229557, rs76358638, rs577739464, rs769061106, rs146388001, rs185661462,
rs758895653, rs767136120, rs397514715 and rs200651392
Disease susceptibility and development of CAAs
Nakamura et al[46]KD + PFAPA (n = 3)WESCARD8rs140826611Inflammasome link (NLRP3 regulation)
Chen et al[21]KD (n = 330)Targeted gene panelCD247, PPIE, FLT4, CUL1, LBP, IL2RA, MAP2K1, MAPK11rs840016, rs2463260, rs56401579, rs56193546, rs10271133, rs2007404, rs12358961, rs16949924, rs2232595, and rs742185IVIG resistance
ACVR2B, CD24rs77317995, rs6530599, rs6530600, rs1136210IVIG responsiveness
Amano et al[38]KD (n = 82)Targeted gene panelIL-4Rrs563535954 IVIG responsiveness
Song et al[39]KD (n = 190)Targeted gene panelITPR3, PIK3CD, PRKCZrs2229634, rs11121484, rs1141402, rs34108055Dysregulated innate immune signaling in KD


Write to the Help Desk